Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Terumo Europe clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Italy, France, Belgium, Germany, Ireland, UK, Spain, Netherlands, Sweden, Poland, Switzerland and Austria registers with Terumo Europe as lead sponsor. Synced 23 Oct 2026
3Current trials
1Recruiting now
0Drugs in these trials
12Trial registers
At a glance

Terumo Europe is the lead sponsor of 3 current clinical trials in our Italy, France, Belgium, Germany, Ireland, UK, Spain, Netherlands, Sweden, Poland, Switzerland and Austria registers. 1 is recruiting patients now. The most common phase is Observational. The most-studied condition is Cardiovascular Disease.

ClinicalTrials.gov trials by status

  • Recruiting133%
  • Not yet open133%
  • Active, closed133%

Trials by phase

  • Observational267%
  • Not applicable133%
01

Clinical trials sponsored by Terumo Europe

3 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular Carcinoma (HCC)
NCT05911633 · ClinicalTrials.gov ↗ · Hepatocellular Carcinoma Non-resectable
Not applicable Recruiting 2024-02 Germany, France, Italy, Belgium
Evaluation of Safety, Performance and Usability of the TR Band DISTAL Device for Hemostasis Following Distal Radial Access in Coronary Procedures
NCT07888738 · ClinicalTrials.gov ↗ · Hemostasis, Distal Radial Artery Access (dTRA)
Observational Not yet open 2026-12 Germany, Italy
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
NCT05705973 · Cardiovascular Disease, Coronary Artery Occlusion, Ischemic Heart Disease
Observational Active, closed 2023-04 Ireland, UK, France, Spain, Italy, Netherlands, Belgium, Sweden, Poland, Switzerland, Austria

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Terumo Europe trials

6 conditions
Cardiovascular Disease1Coronary Artery Occlusion1Ischemic Heart Disease1Hepatocellular Carcinoma Non-resectable1Hemostasis1Distal Radial Artery Access (dTRA)1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Italy31
Clinical trials in France21
Clinical trials in Belgium21
Clinical trials in Germany21
Clinical trials in Ireland10
Clinical trials in UK10
Clinical trials in Spain10
Clinical trials in Netherlands10
Clinical trials in Sweden10
Clinical trials in Poland10
Clinical trials in Switzerland10
Clinical trials in Austria10

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Cardiovascular Disease

SponsorTrials
Fu Jen Catholic University2
Olivier F. Bertrand1

Sponsors with the most current trials registered for this condition.

05

Questions about Terumo Europe trials

How many clinical trials does Terumo Europe sponsor?

Terumo Europe is the lead sponsor of 3 current trials on ClinicalTrials.gov in our Italy, France, Belgium, Germany, Ireland, UK, Spain, Netherlands, Sweden, Poland, Switzerland and Austria registers, as of the registry sync on 23 October 2026. Completed and withdrawn studies are not counted.

Are Terumo Europe trials recruiting?

Yes. 1 of its 3 ClinicalTrials.gov trials is recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Does Terumo Europe have clinical trials in Ireland?

Yes. 1 trial in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 23 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.